PSMA in the News

As part of theranostics service, Nuclear medicine at UPMC Presby-Shadyside has introduced the much-anticipated Lu-177 PSMA therapy program to metastatic prostate cancer patients under compassionate access, the first of its kind in the entire state even before its FDA approval.

https://www.wtae.com/article/prostate-cancer-new-therapy-at-upmc/39455673